跳至主要内容
临床试验/ACTRN12612000036819
ACTRN12612000036819已完成未知

A randomised-controlled trial of oral arginine supplementation on the healing of foot ulcers in patients with type 2 diabetes

orthern Hospital0 个研究点目标入组 8 人开始时间: 2012年1月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Study eligibility will include a confirmed diagnosis of Type 2 diabetes mellitus and a foot ulcer with an International Working Group of the Diabetic Foot (IWGDF) PEDIS classifications (as listed below) of at least 4 weeks duration.
  • 1.Perfusion: Grades 1-3
  • 2.Depth: Grades 1-3
  • 3.Infection: Grades 1-3
  • 4.Sensation: Grades 1 and 2

排除标准

  • Patients with a Grade 4 infection rating according to the IWGDF PEDIS classification system will be excluded as systemic signs will usually require hospital admission. Patients with phenylketonuria, sepsis, chronic renal failure, malignancy, and chronic inflammatory bowel disease, will be excluded for health and safety reasons. Individuals receiving hydroxyurea or greater than 10 mg prednisolone or 1.5 mg dexamethasone per day will also be excluded as these drugs can impact on the rate of healing of diabetic foot ulcers. Individuals using insulin to manage their diabetes will also be excluded.

研究者

发起方
orthern Hospital

相似试验